Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-25-033607
Filing Date
2025-07-01
Accepted
2025-06-30 21:52:19
Documents
4
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 6-K cybininc-form6xk06x30x2025.htm 6-K 13702
2 EX-99.1 cybn-q42025earningsprfinal.htm EX-99.1 39554
3 EX-99.2 pressreleaserehightrailtra.htm EX-99.2 34526
4 GRAPHIC image_0.jpg GRAPHIC 14343
  Complete submission text file 0001628280-25-033607.txt   108727
Mailing Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9
Business Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9 (908) 764-8385
CYBIN INC. (Filer) CIK: 0001833141 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-40673 | Film No.: 251094019
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)